Service expected to help companies discover partners in funding.
Pharma Targeting, a pharmaceutical market intelligence and data company, has announced the launch of ‘Partner Identifier’, an initiative designed to help pharma and biotech companies find the partners they need to get funded, noticed, and faster to market. According to the organization, the technology uses data-driven intelligence to help customers identify and engage with the right partner for licensing, in-licensing, funding, distribution, and other business needs.
“The Partner Identifier was born out of a client need, adjusted, and implemented to help them to identify and engage with the right partner, at the right time, with an aligning strategy and the necessary funds in place,” says Anil Kumar, founder, Pharma Targeting. “We do the challenging work of finding and contacting our clients’ potential partners, so that all they have to do is make connections and build relationships. The ultimate goal is helping our clients to achieve meaningful collaboration and partnership, and get their products to market quicker.”
Reference:
Pharma Targeting Launch ‘Partner Identifier’ to Intelligently Connect the Dots between Data and Business Opportunity for Pharma Clients. (2023, July 6).
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?
October 25th 2024Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.